Connect Conference & Show Floor Educational Sessions

View, browse and sort the list of Connect Conference sessions and show floor programming by pass type, track, and format. Please note, all Connect Conference delegates have access to CPhI Connect and InformEx Connect programming. Seating is first come, first serve, so please arrive early to sessions that you would like to attend. Sessions are subject to change.

To learn more about the Connect Conference program, click here.

All SessionsSpeakersMy Schedule
View Sessions As:
  
  • Continuous Solid Dose Manufacturing - Analytics to Support the Supply Chain

    Speakers:
    • Stephen V. Hammond  |  Senior Director/Team Leader of the Process Analytical Sciences Group, Pfizer Global Technology
    • Benoît Igne, Ph.D.  |  Scientific Leader, GSK Fellow, GlaxoSmithKline
    Location:  113B
    Track: Drug Manufacturing
    Pass Type: Connect Delegate, VIP Attendee - Get your pass now!
    Vault Recording: TBD

    To be an effective contributor to a transformed "low inventory - pull" medical products supply chain, manufacturing of pharmaceuticals must also transform. The large scale batch processing, in centralized facilities does not serve the new supply chain well. The need for flexibility and localization of manufacturing in Emerging Markets is becoming a primary objective for the development of new processing technologies in the pharmaceutical industry. This paper will describe some of the efforts that Pfizer and the industry in general, are putting into the concepts of continuous manufacturing, married together with integrated analytics and Advanced Control Systems. The combined technologies allow for rapid response to demand, through flexible low inventory supply streams that occupy a small footprint, and can be rapidly deployed to markets anywhere in the world. Interfacing PAT's into a continuous manufacturing system requires consideration of patient safety, compliance to existing standards but also supply flexibility and reliability. This paper will describe the on-going efforts to develop analytics and controls to respond to these considerations. Emphasis will be placed on the need for a measurement and control system that is based on the business need, as well as satisfying the need for patient safety and compliance.